Anavex Life Sciences Corp (AVXL)

[Investor2014]

48 weeks in mild AD patients is a relatively short time in which to detect clear change in Activities of Daily Living.

they still aren’t revealing LSM of ADL change. I understand it’s not statistical sig. but why hide it.

That is a well document issue and here the biomarkers are very helpful as a backup to the outcome of a mild AD trial.

Let's see AA is potentially within reach. I now feel exonerated for my generous 25% chance.